scotPHO introduction:
  Allergic conditions
  Cancer
  Overview
  Breast Cancer
  Colorectal Cancer
  Lung Cancer
  Key points
  Introduction
  Risk factors
  Policy context
  Data
  Key data sources
Key references
  Useful links
  Prostate Cancer
  CHD
  Diabetes
  Disability
  Epilepsy
  Hepatitis C
  Immunisations
  Infections
  Mental Health
  Multiple Sclerosis
  Oral Health
  Stroke
  Suicide
Text Only  |  Text Size: A |  A+ |  A++

Lung cancer: key references

Black R, Stockton D (eds).  Cancer scenarios: An aid to planning cancer services in Scotland in the next decade.  Edinburgh: Scottish Executive, 2001.

Brewster DH, Stockton DL, Harvey J, Mackay M.  Reliability of cancer registration data in Scotland, 1997.  Eur J Cancer 2002; 38: 414-417.

Clinical Standards Board for Scotland. Lung Cancer Services: National Overview. Edinburgh: CSBS, 2002.PDF Button

Crispo A, Brennan P, Jockel KH, Schaffrath-Rosario A, Wichmann HE, Nyberg F, Simonato L, Merletti F, Forastiere F, Boffetta P, Darby S. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 2004; 91: 1280-1286.
 
Ferlay J, Bray F, Pisani P, Parkin DM.Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0. Lyon: IARCPress, 2004. Lyon: IARCPress, 2004.  (The GLOBOCAN database is an electronic version of this).

Forman D, Stockton D, Moller H, Quinn M, Babb P, De Angelis R, Micheli A. Cancer Prevalence in the UK: results from the EUROPREVAL Study.  Annals of Oncol 2003; 14: 648-654.

Gillis CR, Hole DJ, Hawthorne VM.  Cigarette smoking and male lung cancer in an area of very high incidence. II. Report of a general population cohort study in the West of Scotland.  J Epidemiol Community Health 1988; 42: 44-48.
 
Gregor A, Thomson CS, Brewster DH, Stroner PL, Davidson J, Fergusson RJ, Milroy R, on behalf of the Scottish Cancer Trials Lung Group and the Scottish Cancer Therapy Network.  Management and survival of lung cancer patients diagnosed in 1995 in Scotland: results of a national, population-based study.  Thorax 2001; 56: 212-217.

Harkness EF, Brewster DH, Kerr KM, Fergusson RJ, MacFarlane GJ.  Changing trends in incidence of lung cancer by histological type in Scotland.  Int J Cancer 2002; 102: 179-183.

Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R & the EUROPREVAL Working Group. Cancer prevalence in European registry areas.  Annals of Oncology 2002; 13: 840–865.

Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321: 323-329.

Scottish Executive Health Department. Cancer in Scotland: Action for change.  Edinburgh: Scottish Executive, 2001.

Scottish Executive Health Department. Cancer in Scotland: Sustaining change.  Edinburgh: Scottish Executive, 2004.

Scottish Intercollegiate Guidelines Network. SIGN80 Management of patients with lung cancer. Edinburgh: SIGN, 2005.PDF Button

Stockton DL. Sustaining Change: cancer Incidence Projections for Scotland (2001-2020). An Aid to Planning Cancer Services. Edinburgh: Scottish Executive, 2004.

Wood H, Cooper N, Rowan S, Quinn M. Lung. In: Quinn M, Wood H, Cooper N, Rowan S (eds). Cancer Atlas of the United Kingdom and Ireland 1991-2000. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.PDF Button